Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Bibeau buys 100,000 shares @ .095

You are wrong. There are defined instances when an insider may purchase stock when aware of significant non-public material events without being in breech of any legislation.

The significance of a "Final Rejection" is surely based on the grounds for the rejection. Now read what engineers are saying about the examiner's analysis of the '336 and then tell me that it means the end of the patent.

Please stick with facts and not a belief that any one poster has exclusive access to the truth.





Be well

Share
New Message
Please login to post a reply